Moreover, MYCMI-6 significantly inhibited growth of Burkitt’s lymphoma (BL) cells - another classical example of a MYC-driven tumor, having translocations of MYC to one of the immunoglobulin loci - in a dose-dependent manner with an average GI50 of 0.5 μM (Fig. 6A). Here, MYC is linked to Burkitt lymphoma.